Synaptics insider plans sale of 450 shares

Synaptics, Inc. is registering a proposed sale of 450 shares of common stock by an affiliated seller through Morgan Stanley Smith Barney LLC Executive Financial Services, referencing an expected sale date of July 20, 2026 on NASDAQ.

Rhea-AI Filing Summary

Synaptics, Inc. is registering a proposed sale of 450 shares of common stock by an affiliated seller through Morgan Stanley Smith Barney LLC Executive Financial Services, referencing an expected sale date of July 20, 2026 on NASDAQ. The filing notes these securities relate to Restricted Stock Units dated July 17, 2026. It also lists prior sales under a Rule 10b5-1 trading plan for Lisa Bodensteiner, including transactions of 334 shares on June 18, 2026 and 612 shares on May 19, 2026.

Key Figures

Shares to be sold: 450 shares Aggregate market value: $51,320.25 Shares outstanding: 38,637,685 shares +4 more

7 metrics

Shares to be sold 450 shares Common stock proposed for sale on or about July 20, 2026

Aggregate market value $51,320.25 Value associated with 450 shares of common stock

Shares outstanding 38,637,685 shares Common shares outstanding for Synaptics, Inc.

Prior sale May 19, 2026 612 shares Common stock sold under a Rule 10b5-1 plan

Prior sale June 18, 2026 334 shares Common stock sold under a Rule 10b5-1 plan

Proceeds May 19, 2026 sale $70,275.96 Dollar amount listed for 612-share 10b5-1 sale

Proceeds June 18, 2026 sale $46,185.52 Dollar amount listed for 334-share 10b5-1 sale

Key Terms

Form 144, Restricted Stock Units, 10b5-1 Sales, Executive Financial Services

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Common | 07/17/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Synaptics (SYNA) report in this Form 144 filing?

Synaptics reports a proposed sale of 450 shares of common stock related to Restricted Stock Units, expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on July 20, 2026 on NASDAQ.

How many Synaptics (SYNA) shares are proposed to be sold under this notice?

The notice covers a proposed sale of 450 shares of Synaptics common stock. These shares are associated with Restricted Stock Units dated July 17, 2026 and are expected to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

What prior 10b5-1 sales are disclosed for Synaptics (SYNA) insider Lisa Bodensteiner?

The filing lists two prior Rule 10b5-1 sales for Lisa Bodensteiner: 612 shares of common stock on May 19, 2026 and 334 shares on June 18, 2026, with stated dollar amounts for each transaction.

What aggregate market value is associated with the Synaptics (SYNA) shares to be sold?

The proposed 450-share sale of Synaptics common stock is associated with an aggregate market value of $51,320.25, as stated in the filing, in connection with trading on NASDAQ.

How many Synaptics (SYNA) shares are reported as outstanding in this filing?

The filing cites 38,637,685 shares of Synaptics common stock as outstanding. This figure is presented for context regarding the issuer’s total outstanding shares and is separate from the 450 shares proposed for sale.

What type of security is being sold in this Synaptics (SYNA) Form 144?

The security is common stock, originating from Restricted Stock Units dated July 17, 2026. The planned sale of 450 shares is to occur on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001213272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNAPTICS INCORPORATED
SEC File Number	000-49602
Address of Issuer	1109 McKay Drive San Jose CALIFORNIA 95131
Phone	4089041100
Name of Person for Whose Account the Securities are To Be Sold	LISA BODENSTEINER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	450	51320.25	38637685	07/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/17/2026	Restricted Stock Units	Issuer			450	07/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	06/18/2026	334	46185.52
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	05/19/2026	612	70275.96

144: Remarks and Signature

Remarks
Date of Notice	07/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Lisa Bodensteiner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)